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Objective: We report the first pediatric specific Phenome-Wide Association Study
(PheWAS) using electronic medical records (EMRs). Given the early success of PheWAS
in adult populations, we investigated the feasibility of this approach in pediatric cohorts in
which associations between a previously known genetic variant and a wide range of clinical
or physiological traits were evaluated. Although computationally intensive, this approach
has potential to reveal disease mechanistic relationships between a variant and a network
of phenotypes.
Method: Data on 5049 samples of European ancestry were obtained from the EMRs of two
large academic centers in five different genotyped cohorts. Recently, these samples have
undergone whole genome imputation. After standard quality controls, removing missing
data and outliers based on principal components analyses (PCA), 4268 samples were
used for the PheWAS study. We scanned for associations between 2476 single-nucleotide
polymorphisms (SNP) with available genotyping data from previously published GWAS
studies and 539 EMR-derived phenotypes. The false discovery rate was calculated and,
for any new PheWAS findings, a permutation approach (with up to 1,000,000 trials) was
implemented.
Results: This PheWAS found a variety of common variants (MAF > 10%) with prior GWAS
associations in our pediatric cohorts including Juvenile Rheumatoid Arthritis (JRA), Asthma,
Autism and Pervasive Developmental Disorder (PDD) and Type 1 Diabetes with a false
discovery rate < 0.05 and power of study above 80%. In addition, several new PheWAS
findings were identified including a cluster of association near the NDFIP1 gene for mental
retardation (best SNP rs10057309, p = 4.33× 10−7, OR = 1.70, 95%CI = 1.38 − 2.09);
association near PLCL1 gene for developmental delays and speech disorder [best SNP
rs1595825, p = 1 8.13× 10− , OR = 0.65(0.57 − 0.76)]; a cluster of associations in the
IL5-IL13 region with Eosinophilic Esophagitis (EoE) [best at rs12653750, p = 3.03× 10−9,
OR = 1.73 95%CI= (1.44− 2.07)], previously implicated in asthma, allergy, and eosinophilia;
and association of variants in GCKR and JAZF1 with allergic rhinitis in our pediatric cohorts
[best SNP rs780093, p = 2.18× 10−5, OR = 1.39, 95%CI = (1.19 − 1.61)], previously
demonstrated in metabolic disease and diabetes in adults.
Conclusion: The PheWAS approach with re-mapping ICD-9 structured codes for our
European-origin pediatric cohorts, as with the previous adult studies, finds many previously
reported associations as well as presents the discovery of associations with potentially
important clinical implications.
Keywords: PheWAS, ICD-9 code, genetic polymorphism
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INTRODUCTION
Phenome-wide association study (PheWAS) is a relatively new
genomic approach to link clinical conditions with published vari-
ants (Denny et al., 2010). The concept, although not new, was
originally applied to genomic research by the eMERGE (electronic
MEdical Records and GEnomics) network, which is in a unique
position to access tens of thousands of ElectronicMedical Records
(EMR) linked to ICD-9 codes in structured data. Multiple
eMERGE PheWAS results have been published that primarily
address adult cohorts (Denny et al., 2011, 2013). The phenotypic
data used in PheWAS may include ICD-9 codes, epidemiologic
data in health surveys, biomarkers, intermediate or quantitative
traits (Pendergrass et al., 2011, 2013; Neuraz et al., 2013; Liao
et al., 2014). By virtue of this inclusive approach, new hypotheses
may be generated that provide insight into genetic architecture
of complex traits. Challenges with PheWAS include multiple test
corrections across the thousands of phenotypes tested and auto-
correlation of some of the phenotypes. Nevertheless, novel robust
insights have resulted from PheWAS, for example, genetic associ-
ation findings with heart rate variability are notable (Ritchie et al.,
2013).
PheWAS combinesmultiple phenotypes from previous GWAS,
and identify common SNPs affecting different traits. In this study,
we used this approach to evaluate whether known GWAS vari-
ants identified in adult diseases can be also identified in children
using two EMR-linked pediatric datasets from eMERGE. PheWAS
in pediatrics is particularly important because it not only assesses
the effect of early age of onset on many established adult-GWAS
loci, but also may provide insights into how a primary pheno-
type during child development develops into one ormore diseases
in adulthood. A priori, there are several reasons that in principle
might make a pediatric PheWAS more challenging. These include
the change in heritability with age for several traits (St Pourcain
et al., 2014), the flux in the recommendations for pediatric mon-
itoring for traits that are routinely measured in adults (Gidding,
1993; Klein et al., 2010) and the use of cross-sectional standard-
ization rather than longitudinal standardization of developmental
traits such as height (Tiisala and Kantero, 1971).
To determine whether robust association signals would be
present in the context of these challenges, we conducted the first
PheWAS study in pediatrics on our available samples. We suc-
cessfully translated 93,724 specific ICD-9 diagnostic codes into
1402 distinct PheWAS code groups and 14 major disease concept
paths and evaluated 2481 previously published variants. After
quality control, only 2476 genetic variants were analyzed in 539
diseases in the two pediatric sites. Finally we replicated 24 genetic
variants and identified 14 new possible associations confirming
our hypothesis. Our primary results highlight the utility of an
EMR-based PheWAS approach as a new line of investigation for
discovery of genotype-phenotype associations in pediatrics.
MATERIALS AND METHODS
STUDY SUBJECTS
Protocols for this study were approved by the Institutional
Review Boards (IRBs) at the institutions where participants
were recruited. All study participants provided written con-
sent prior to study enrolment; consent forms were obtained at
each location under IRB guidelines. Children and teens, aged
through 19 years old were included. The EMR-linked pedi-
atric emerge cohorts consist of 4560 subjects from Cincinnati
Children’s Hospital Medical Center (CCHMC) and 1000 subjects
from Boston Children’s Hospital (BCH). Only those self-reported
to have European ancestry were selected for this study (Table 1).
SNP PRIORITIZATION
We limit our investigation to particular genetic variants: First,
we obtained the list of all previously published SNPs from
different public domain databases including The National
Human Genome Research Institute (NHGRI) catalog of pub-
lished Genome-Wide Association Studies (http://www.genome.
gov/gwastudies), Genetic Association of Complex Diseases
and Disorders (GAD, http://geneticassociationdb.nih.gov), the
UCSC Genome Browser database (UCSC, http://genome.ucsc.
edu/), Online Mendelian Inheritance in Man (OMIM, http://
www.omim.org/), and PharmGKB (pharmgkb, https://www.
pharmgkb.org). After linking this collection to PubMed refer-
ence numbers, only those with at least one reported of positive
associations were selected regardless of the previously observed
p values or number of publications. In addition, all down-
loaded databases were current at the time of this submission.
From the filtered variants, 2476 variants were available and
assessed in our clean, post-imputation genotyping dataset for
analysis.
GENOTYPING AND STATISTICAL ANALYSES
High throughput SNP genotyping was carried out previously
in CCHMC and BCH using Illumina™ or Affymetrix™ plat-
forms, as previously described (Namjou et al., 2013). Quality
control (QC) of the data was performed before imputation. In
each genotyped cohort, standard quality control criteria were met
and single nucleotide polymorphisms (SNPs) were removed if
(a) >5% of the genotyping data was missing, (b) out of Hardy-
Weinberg equilibrium (HWE, p < 0.001) in controls, or a minor
allele frequency (MAF) <1%. Samples with call rate <98% were
excluded.
Recently all eMERGE cohorts have also undergone whole
genome imputation. The details of these procedures are avail-
able in this issue of Frontiers in Genetics (Setia et al.,
2014). Briefly, the imputation pipeline was implemented using
IMPUTE2 program and the publicly available 1000-Genomes
Project as the reference haplotype panel composed of 1092 sam-
ples (release version 2 from March 2012 of the 1000 Genomes
Project Phase I, ftp://ftp-trace.ncbi.nih.gov/1000genomes/ftp/
release/20110521) (Howie et al., 2011). The eMERGE imputed
data provided to us were already filtered, i.e., imputed data with a
threshold of 0.90 for the genotype posterior probability and with
a IMPUTE2 info score > 0.7 (Howie et al., 2011). Principle com-
ponent analysis (PCA) performed to identify outliers and hidden
population structure using EIGENSTRAT (Price et al., 2006). The
first two principle components explained most of the variance
and were retained and used as covariates during the association
analysis in order to adjust for population stratification. In addi-
tion, 14 outlier samples were removed. To illustrate the overall
inflation rate a phenotype with sufficient number of cases and
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Table 1 | The demographic distribution of the European ancestry population (CCHMC-BCH).
Cohort names #Europeans M/F Mean age (95%CI) Array
BCH* The gene partnership 727 449/278 13.30(12.97–13.66) Affymetrix-Axiom
CCHMC** Cytogenetics 1228 758/470 7.32(7.03–7.62) Illumina-610
Cytogenetics 609 373/236 7.18(6.73–7.63) Illumina-Omni-1
EoE† 543 394/149 12.27 (11.70–12.67) Illumina-Omni-5
JIA‡ 488 101/387 13.70(13.13–14.23) Affymetrix-6
Cincinnati- control cohorts 673 329/344 13.50(13.25–13.84) Illumina-Omni-5
Total 4268 2403/1865 11.52(11.16–11.91)
*BCH, Boston Children’s Hospital; **CCHMC, Cincinnati Children’s Hospital Medical center; †, Eosinophilic Esophagitis (EoE) cohorts; ‡, Juvenile Idiopathic Arthritis
cohorts (JIA). The details of platforms used have been described elsewhere (Namjou et al., 2013).
controls has been selected (autism) and the inflation of λ = 1.03
was obtained.
Next, from our prioritized SNP list mentioned above, 2481
variants were available. Five of these SNPs had a site-specific
effect with either CCHMC or BCH (p < 10−5 for the differ-
ence between sites) and were removed from final analyses. For
each phenotype, logistic regression was performed between cases
and control adjusted for two principal components using PLINK
(Purcell et al., 2007). To investigate whether either the pheno-
type or the genotype has an effect on the outcome variable, we
perform phenotypic and genotypic conditional analyses, control-
ling for the effect of a specific SNP or phenotype. After pruning
of highly correlated SNPs (r2 > 0.5), we used false discovery
rate (FDR) methods to correct for multiple testing using the
Benjamini–Hochberg procedure implemented in PLINK (Purcell
et al., 2007). As a result of LD pruning 1828 independent variants
were used for the purpose of FDR estimation. Q values corre-
spond to the proportion of false positives among the results. Thus,
Q values less than 0.05 signify less than 5% of false positives
and are accepted as a measure of significance (FDR < 0.05) in
this study. For any novel PheWAS findings, an adaptive permu-
tation approach was performed using a sample randomization
strategy in which case and control labels were permuted ran-
domly (with up to 1,000,000 trials) in order to obtain empirical
p values [PLINK (Purcell et al., 2007)]. We also report previ-
ous known effects that only produce suggestive findings in our
study (0.05 < p < 0.001). Sample size and power calculations
based on the size effect and risk allele frequency were esti-
mated using QUANTO (Gauderman and Morrison, 2006). To
graphically display results, LocusZoom was used (Pruim et al.,
2010).
PHENOTYPING
A phenome-wide association analysis (PheWAS) was performed
in which presence or absence of each PheWAS code [mapped
from translated ICD-9 codes as per Carroll et al., 2014)] were
considered as a binary phenotype. The per-patient ICD-9 codes
were obtained from the i2b2 Research Patient Data Warehouse
at CCHMC and BCH. Also, these PheWAS codes were used
to define comparison control groups by excluding the PheWAS
case- code and those closely related to them in the ICD-9 hier-
archy. Control groups for Crohn’s Disease (CD), for instance,
excluded CD, ulcerative colitis, and several other related gas-
trointestinal complaints. Similarly, control groups for myocardial
infarction excluded patients with myocardial infarctions, as well
as angina and other evidence of ischemic heart disease. The
current PheWAS map and PheWAS script written in R is avail-
able [http://phewascatalog.org, (Carroll et al., 2014)]. In this
study, subgroups of European cases with more than 20 samples
were selected for PheWAS association study (539 subgroups) and
the available published SNPs that passed quality controls were
evaluated. The case cohorts for the two phenotypes of Juvenile
Idiopathic Arthritis (JIA) and Eosinophilic Esophagitis (EoE)
have both been previously published as parts of larger phenotype
specific studies (Rothenberg et al., 2010; Thompson et al., 2012;
Hinks et al., 2013). The origin of all case records is presented in
Table 1. In this study, Juvenile Onset Rheumatoid Arthritis (JRA)
is identified by ICD-9 codes and designated as JRA; when the cri-
teria for Juvenile Idiopathic Arthritis (JIA) were applied in the
studies of others (Thompson et al., 2012), then this phenotype
was referred to as JIA.
RESULTS
In this study only European ancestry was included in the analy-
sis to avoid potential bias induced by ancestry. The demographic
distribution of the European ancestry population under study
(Table 2) had 93,724 specific ICD-9 diagnostic codes representing
1402 distinct PheWAS code groups and 14 major disease concept
paths. The frequencies of concept path hierarchy of the ontology
(Figure 1) show the neuropsychiatric concept path as the most
frequent and neoplastic and infection paths as the least frequent.
Replication of existing associations using PheWAS
We compared SNPs with previous GWAS-reports and present
association findings (FDR-q < 0.05) after corrected for popula-
tion stratification and standard quality control (Table 2).
First, for the two phenotypes of JRA and EoE samples overlap
largely with those previously reported phenotype specific GWAS
study (Rothenberg et al., 2010; Thompson et al., 2012; Kottyan
et al., 2014). We reproduced the major findings of those publi-
cations using different methodology. For JRA, association with
PTPN22 is a consistent finding. As expected, we replicated a previ-
ous report of association of PTPN22 at non-synonymous coding
SNP rs2476601 with this phenotype and with the same direction
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FIGURE 1 | Frequency and distribution of 14 major ontology concept path categories from CCHMC/BCH European pediatric cohorts.
of allele frequency, (p = 9.10× 10−7, OR = 1.87, 95%CI 1.46 −
2.40). The SNP in proxy (rs6679677, r2 = 1) also produced a
similar result (Table 2). In our cohorts, variants in PTPN22 are
also associated with thyroiditis as well as Type 1 diabetes mel-
litus (T1DM), consistent with previous reports and despite low
sample size (Table 2) (Plenge et al., 2007; Todd et al., 2007; Lee
et al., 2011). From these three known associations of PTPN22,
i.e., JRA, T1DM, and thyroiditis, the largest magnitude of the
association is with pediatric onset thyroiditis (Table 2,OR = 3.52
95%CI 1.84− 6.75).
For JRA, multiple loci in the HLA region were also associ-
ated at the level of p < 10−12 including rs477515 and rs2516049
near HLA-DRB1 (Table 2). Of note, the size effect of HLA related
SNPs, were highest for those with coexisting uveitis (best SNP
rs477515, OR = 6.5, 95% CI = 2.73 − 15.68 for the risk allele,
Table 2). In addition, for JRA, another previously published asso-
ciation (rs12411988 in REEP3) was also found and with the
same size effect as previously described (OR = 1.53) (Table 2)
(Thompson et al., 2012).
Furthermore, with regard to EoE traits, we also replicated pre-
vious major finding of association of SNP rs3806932 located at
the vicinity of the TSLP gene at 5q22 region [p = 5.59× 10− 7,
OR = 0.69 (95%CI = 0.59 − 0.80)] in these cohorts (Table 2)
(Rothenberg et al., 2010; Kottyan et al., 2014).
For asthma, the best PheWAS results were detected at 17q21
which includes GSDMB and has been previously reported to
be associated specifically with childhood onset Asthma (Verlaan
et al., 2009). In fact, the best associated SNP rs8067378 in our
cohorts [p = 3.13× 10−6, OR = 1.37 (1.19 − 1.57)], tags the
asthma associated haplotype in which the allele-specific expres-
sion analyses for this haplotype has previously shown strong
association with Asthma risk (Verlaan et al., 2009). There is strong
support for this association from a cluster of variants in this
neighborhood (Figure 2A).
The minor allele (T) of the intronic SNP rs7903146 in TCF7L2
is one of the larger magnitude and more frequently identified
associations in Type 2 diabetes mellitus (T2DM) and hyper-
lipidemia in many adult GWAS studies (Lyssenko et al., 2007;
Huertas-Vazquez et al., 2008). In fact, the best PheWAS trait in
our cohorts at this variant was also related to T2DM and hyper-
lipidemia as well, although our sample size was small. In this
family of ICD-9 codes the best suggestive result was obtained for
an abnormal glucose test with [p = 0.001, OR = 2.00 (95%CI
1.29− 3.08)] (Table 2).
Specifically, for T1DM, in addition to the positive associa-
tion with PTPN22 mentioned above, additional published loci
were confirmed and with relatively larger effect sizes (OR > 2)
including known HLA-SNP rs660895 [p = 7.85× 10−7, OR =
2.73 (95%CI = 1.80 − 4.13)], as well as variants near CENPW
that previously have been reported for this trait (Table 2) (Barrett
et al., 2009).
Other effects
Several loci previously associated with autism and pervasive
developmental disorders (PDD) (GWAS or copy number vari-
ations reports) including those at MACROD2, ITGB3, CADM2,
and GRIK2 (Jamain et al., 2002; Weiss et al., 2006; Thomas
et al., 2008; Anney et al., 2010) also provided evidence of asso-
ciation in our cohorts for these traits (Table 2). Variants in the
FOXE1 gene that have been previously associated with primary
hypothyroidism and thyroiditis in adult eMERGE cohorts (Denny
et al., 2011), produced a trend of association and consistent in
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FIGURE 2 | Association results and signals contributing to Asthma,
Eosinophilic Esophagitis, Mental Retardation, and Developmental
Delays. SNPs are plotted by position in a 0.2Mb window against association
signals (−log10 P-value). For each trait, the most significant SNP is
highlighted. Estimated recombination rates (from HapMap) are plotted in
cyan to reflect the local LD structure. The SNPs surrounding the most
significant SNP, are color-coded to reflect their LD with identified SNP (taken
from pairwise r2 values from the HapMap CEU database, www.hapmap.org).
Regional plots were generated using LocusZoom (http://csg.sph.umich.edu/
locuszoom). (A) Cluster of the association effect for asthma at 17q21 near the
gasdermin-B (GSDMB) gene. (B) Association signal for Eosinophilic
Esophagitis at 5q31 (IL5-IL13 cluster region). (C) Cluster of association near
the NDFIP1 gene for Mental Retardation traits. (D) Plot of association effects
in the PLCL1 region for Developmental Delays-Speech Disorders.
directionality with thyroiditis in our pediatric cohorts despite
low sample size (Table 2). No gene-gene interaction was evident
between PTPN22 and FOXE1 for hypothyroidism in these data.
Rs7574865 is a SNP in the third intron of the STAT4 that has been
associated with SLE and related autoimmune diseases (Namjou
et al., 2009). In these cohorts, pediatric onset lupus was under-
represented (less than 20 cases), however, suggestive associations
with wheeze and asthma were detected [p = 0.004, OR 1.46
(95%CI = 1.11 − 1.92) (Table 2)] with the same direction of the
difference in allele frequency previously observed in autoimmune
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traits. This possible association has also been reported in another
study (Pykäläinen et al., 2005). Of note, in contrast to rheumatoid
arthritis, the STAT4 association effect was weak for JRA in our
cohorts (effect size = 1.12, p = 0.17). GWAS studies have linked
Inflammatory Bowel disease (IBD) to a number of IL-23 path-
way genes, in particular IL23R. The well-known coding variant in
the IL23 receptor (rs11209026) also showed a trend toward asso-
ciation with IBD in our cohorts with the same allelic direction
but due to low sample size (31 cases) it did not reach significance
(FDR-q> 0.05) (Li et al., 2010) (data not shown).
Novel findings from this PheWAS
A number of potentially novel associations remained significant
after the permutation procedure to assess the probability of the
observed distribution with beta > 0.8 FDR-q < 0.05 (Table 3).
Variants in the Glucokinase Regulator gene (GCKR) have been
previously implicated in metabolic disease, diabetes and hyper-
triglyceridemia in adults (Bi et al., 2010; Onuma et al., 2010)
and were mostly associated with allergic rhinitis in our pediatric
cohorts [best SNP rs780093 p = 2.18× 10−5, p(perm) = 8.06×
10−5,OR = 1.39, 95%CI= (1.19− 1.61)] (Table 3), while no sig-
nificant association was found for diabetes. Indeed, conditional
analyses, controlling for diabetes related traits suggest that this
is an independent effect (p-conditional = 6.75× 10−5). Another
major regulatory locus for diabetes in adults, JAZF1, also was
associated with allergic rhinitis in our cohorts (Table 3) even
after controlling for diabetes (p-conditional = 8.46× 10−5, for
rs1635852). No significant gene-gene interaction was detected
between these two loci or with TCF7L2.
Variants in a cytokine cluster of the IL5-IL13 region, which is
known to be associated with Asthma, Allergy, Atopic Dermatitis
(AD) and Eosinophilia, produced a cluster of association with
EoE in our cohorts [best SNP rs12653750, p = 3.03× 10−9,
p(perm) = 1.00× 10−6,OR = 1.73 (1.44− 2.07)] (Bottema et al.,
2008; Granada et al., 2012). There is a cluster of significant vari-
ants in this neighborhood of chromosome 5 (5q31) associated
with EoE (Figure 2B). In our cohorts, weaker associations can
be detected for all allergy-related phenotypes with the associa-
tion with Eosinophilia being the most impressive [p = 9.74×
10−5 (Table 2)]. However, conditional analyses and controlling
for Asthma and Eosinophilia suggest that an independent effect
still exists for EoE at this locus using EMR data (conditional
p = 9.74× 10 - 5 for rs20541). Moreover, no long distance link-
age disequilibrium between rs3806932 in TSLP gene at 5q22 and
rs20541 was detected in this population (r2 = 0.0002,D’= 0.02).
We also observed association with AD within this cytokine
cluster consistent with previous reports (Paternoster et al., 2011).
However, the best associated SNP for AD (rs272889) was located
at SLC22A4 in our population (Table 2). These two variants,
rs272889 and rs12653750, were separated by more than 300kb
with low linkage disequilibrium (r2 < 0.1). A residual effect still
exists for AD and rs272889 after controlling for EoE status or the
rs12653750 variant that suggests a distinct effect (p-conditional=
0.002). Noteworthy, with regard to AD, another reported SNP
(rs2897442) downstream of this cluster at KIF3A gene produced
only a suggestive association (p = 0.005) in our cohort (data not
shown). Ta
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Because of the pleotropic effects between EoE and other allergy
related traits, in addition to conditional analyses, we also found
possible synergistic effects. One of the closely related phenotypes
with EoE is the presence of food allergy. When we combined
these two as a subgroup, two additional effects were identified.
One cluster was in IL1RL1 that was previously associated with the
related phenotype, i.e., allergy and asthma (best SNP rs3771180,
p = 5.71× 10−5, Table 2, Torgerson et al., 2011) and another was
in CLEC16A, previously associated with different autoimmune
diseases [best SNP rs12924729, p = 3.34× 10−8 (Table 2), (Mells
et al., 2011)] and was reported as a suggestive effect in recent
GWAS study for EoE (Kottyan et al., 2014).
Variants near RGS cluster of genes on chromosome 1, pre-
viously reported to be associated with IBD and other autoim-
mune diseases (Hunt et al., 2008; Esposito et al., 2010), were
associated with susceptibility to infection, in particular sup-
purative otitis media [best SNP rs10801047, p = 1.61× 10−6,
p(perm) = 2.00× 10−6, OR = 1.77 95%CI= 1.398− 2.24].
New association signals have been detected near the NDFIP1
gene for mental retardation related traits. Variants near this gene
that is expressed mostly in brain, were previously reported to be
associated with IBD through an unknown mechanism and with
a risk effect for major allele (SNP = rs11167764) (Franke et al.,
2010). Instead, we found a risk effect for the minor allele [best
SNP rs10057309, p = 4.33× 10−7, p(perm) = 2.00× 10−6,OR =
1.702, 95%CI = 1.38 − 2.09] (Table 3). Similarly, cerebral palsy,
which is linked tomental retardation, was also associated with this
variant (p = 9.00× 10−4). However, conditional analyses con-
trolling for cerebral palsy suggest an independent effect for overall
mental retardation (conditional p = 8.00× 10−4). Furthermore,
excluding the small number of samples with known chromoso-
mal abnormalities (N < 40) did not affect this result. The overall
cluster effect in this neighborhood for mental retardation bolsters
the suspicion that an association is found here (Figure 2C).
Additionally, for developmental delays of speech and language,
a novel signal effect was detected in the PLCL1 gene at chro-
mosome 2 [best SNP rs1595825, p = 1.13× 10−8, OR = 0.65
(0.57− 0.76)] (Figure 2D, Table 3). Weaker associations (0.01 >
p > 0.00001) were also detected for related neurologic pheno-
types including abnormal movement, lack of coordination and
epilepsy at this locus (data not shown).
NRXN3 polymorphisms that have been previously reported to
be associated with substance dependence (Docampo et al., 2012),
smoking behavior and attention related problems (Stoltenberg
et al., 2011), were associated with depression in our pediatric
cohorts (Table 3 Noteworthy, the major allele of our reported
SNP (rs7141420) has been linked to obesity in adult cohorts
(Berndt et al., 2013), while we found association with the minor
allele for depression [p = 4.76× 10−5, OR = 1.78 (1.34− 2.34),
Table 3]. Furthermore, raremicro-deletions in this gene were pre-
viously reported for Autism case reports but these rare variants
are not available to assess in our genotyped cohorts (Vaags et al.,
2012).
DISCUSSION
This first pediatric PheWAS finds 38 associations, 24 previ-
ously known phenotype-genotype associations in a pediatric
population using EMR-linked eMERGE databases and identi-
fied 14 new possible associations at beta > 0.8 and FDR-q <
0.05. From analysis performed on EMR-linked data from 4268
European individuals, we successfully confirmed several major
effects for phenotypes with moderate to large sample size, in par-
ticular for Asthma, Autism, and neurodevelopmental disease as
well as several effects for Type 1 and Type 2 Diabetes (T1DM,
T2DM) and Thyroiditis. Almost all of the significant pheno-
type associations were with common variants (MAF > 10%)
(Tables 2, 3). In addition, we compared and verified the con-
sistency of allele frequency of reported markers among cohorts,
sample collection sites and with CEU-Hapmap data. Considering
a desired power of 0.8, for variants at the fixed allele frequency
of 10% and size effect of 1.5 or above, 200 cases are sufficient
to detect association at an alpha level of 0.05. Indeed, we have
surpassed this level for most of our reported traits. In addition,
for all reported phenotypes the control sample was at least two
or three times larger than cases (Tables 2, 3). Importantly, since
our control samples for each trait are an EMR-derived population
and not healthy individuals, this large number of control samples
provides minor allele frequencies consistent with hapmap-CEU
frequencies for all of our reported variants.
The results for JRA and EoE depend upon previously pub-
lished studies of these phenotypes. While the case samples are
mostly identical, the control samples were substantially differ-
ent. Consequently, we cannot refer to these particular findings
as constituting confirmation and yet our results and different
methodology support the previous reports.
In addition, we also identified several novel PheWAS find-
ings for pediatric traits in particular for Allergic Rhinitis, Otitis
Media, EoE, Mental Retardation, and Developmental Delays all
with sufficient power (beta > 0.8) (Table 3, Figures 2B–D). This
study, however, is underpowered to make discoveries for rare
variants or uncommon traits. The power to detect a finding in
PheWAS is determined by many factors, including sample size,
risk allele frequency, effect size, model of inheritance, the effect
of environment and the prevalence of a phenotype within the
population.
Similar to previous studies, we also observed pleiotropy for
a number of loci in particular PTPN22 for JRA, T1DM, and
Thyroiditis, IL5 for Eosinophilia, Asthma, and EoE and NDFIP1
for Mental Retardation traits and Cerebral Palsy. These pleotropic
effects are specifically expected to be due to underlying biologic
correlations. On the other hand, we rarely observed simultaneous
robust associations with multiple unrelated phenotypes that had
sufficient power. Furthermore, one of the advantages of PheWAS
studies is the ability to control the granularity of a database with
regard to related phenotypes. For example, by combining two
related phenotypes such as uveitis with JRA or food allergy with
EoE, we were able to evaluate new subgroups and identify new loci
responsible for shared underlying pathways that otherwise cannot
be detected or require much larger sample sizes. Further stud-
ies with larger sample sizes would be useful to test and perhaps
corroborate these findings.
Association of Allergic Rhinitis with loci responsible for dia-
betes in adults (GCKR-JAZF1) may highlight a shared underlying
mechanism. In fact, the connection between allergy and diabetes
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has been previously suggested in humans but cannot be explained
by the Th1/Th2 paradigm (Dales et al., 2005). Moreover, in ani-
mal experiments, treating mice with mast cell-stabilizing agents
reduced diabetes manifestations (Liu et al., 2009). It is also pos-
sible that in our pediatric cohorts we have under-diagnosed
children who are diagnosed with diabetes which would appear in
a later stage of development. In fact, GCKR is an inhibitor of glu-
cokinase (GCK), a gene responsible for the autosomal dominant
form of T2DM that usually develops later in life and in adulthood.
Of note, neither of these two loci showed significant association
with Body Mass Index (BMI) in our previous report with these
data nor has the obesity link been established in adult studies
(Namjou et al., 2013).
The novel association of a cytokine cluster in the IL5-IL13
region for the EoE trait is particularly interesting since anti-
IL5 monoclonal antibodies have been recommended as a novel
therapeutic agent for EoE and other eosinophilia–related traits
(Corren, 2012). In general, both IL5 and IL13 play a major
role for regulation of maturation, recruitment, and survival of
eosinophils and the variant reported here has been previously
associated with other allergic-related traits and with the same
direction of allele frequency difference (Bottema et al., 2008;
Granada et al., 2012). In particular, a non-synonymous polymor-
phism in the IL13 gene, rs20541 (R130Q) (Table 3), has been
shown to be associated with increased IL-13 protein activity,
altered IL-13 production, and increased binding of nuclear pro-
teins to this region (van der Pouw Kraan et al., 1999). Perhaps,
the association is a reflection of linkage disequilibrium with
another polymorphism in the 5q31 region. In fact, in our anal-
yses residual effect still exists for the best SNP (rs12653750),
shown in Figure 2B after controlling for rs20541 (p-conditional=
2.27× 10−5) (r2 = 0.35). This possible association did not reach
significance in previous GWAS studies for EoE and had only
produced a suggestive effect (0.05 < p < 0.001). Perhaps, this
behavior is explained partly by phenotypic heterogeneity since
minor allele frequency of independent set of both control pop-
ulations were the same. Indeed, we found that those with the
subphenotype of EoE with Eosinophilia had the strongest size
effect (OR = 1.83, 95%CI = 1.44 − 2.32) and our cohorts were
enriched with this subphenotype [177 of total 446 EoE cases
(40%)]. Of note, the SNPs in this region were originally selected
because of eosinophilia-related publications (Bottema et al., 2008;
Granada et al., 2012).
Moreover, combining subgroups of patients with food allergy
and EoE revealed two new loci that may explain shared etiol-
ogy. Indeed, the connection between allergy and Interleukin 1
receptor-like-1 (IL1R1) is already known (Torgerson et al., 2011).
The ligand for IL1R1, IL-33, is a potent eosinophil activator
(Bouffi et al., 2013). Interestingly, there is also a report of associa-
tion of CLEC16A variants with allergy in large analysis with more
than 50,000 subjects from 23andMe Inc. (Hinds et al., 2013). C-
type lectin domain family 16, also known as CLEC16A, is mostly
associated with autoimmune related traits and is highly expressed
in B lymphocytes and natural killer cells. The molecular and
cellular functions of CLEC16A are currently under investigation.
Our conditional analyses suggest an independent effect at the
SLC22A4 gene for Atopic Dermatitis. This solute carrier family
gene is predominantly expressed in CD14 cells and has an impor-
tant role for elimination of many endogenous small organic
cations as well as a wide array of drugs and environmental tox-
ins. The associated SNP, rs272889, has been previously shown to
be correlated with blood metabolite concentration (Suhre et al.,
2011). Other variants in this gene were associated with IBD and
Crohns disease as well (Feng et al., 2009). Of note, a key substrate
of this transporter is ergothioneine, a natural antioxidant, which
Mammalia acquire exclusively from their food. Ergothionine is
a powerful antioxidant though its precise physiological purpose
remains unclear.
Asthma is associated at the 17q21 in our cohorts (Figure 1).
The best associated SNP, rs8067378, is known to function as a cis-
regulatory variant that correlates with expression of the GSDMB
gene (Verlaan et al., 2009). Variants in GSDMB have been shown
to determine multiple asthma related phenotypes specifically in
childhood asthma including associations with lung function and
disease severity (Tulah et al., 2013). These gasdermin-family genes
are implicated in the regulation of apoptosis mostly in epithelial
cells and have also been linked to cancer; however, their actual
function with respect to disease association remains unknown.
The associated variants in this cluster are suspected to be regula-
tory SNPs that govern the transcriptional activity of at least three
nearby genes (ZPBP2, GSDMB, and ORMDL3) (Verlaan et al.,
2009).
We confirmed several loci responsible for Autism and
Pervasive Developmental Disease including MACROD2, ITGB3,
CADM2, and GRIK2. ITGB3 has been known as a quantita-
tive trait locus (QTL) for whole blood serotonin levels (Weiss
et al., 2004, 2006). Serotonin is a monoamine neurotransmit-
ter that has long been implicated in the etiology of Autism. In
fact, about 30 percent of patients with autism have abnormal
blood serotonin levels (Weiss et al., 2004). Similarly, GRIK2 is
an ionotropic glutamate receptor associated with autism (Cook,
1990; Cook et al., 1997). CADM2 is a member of the synaptic cell
adhesion molecule with roles in early postnatal development of
the central nervous system (Thomas et al., 2008). The function
of MACROD2 (previously c20orf133) is still largely unknown.
For Autism that is more commonly seen in males, we found no
significant gender effect for these loci.
Association of variants in the neighborhood of RGS cluster
genes with suppurative otitis media is another novel finding.
SNPs in this region have been previously linked to celiac dis-
ease, multiple sclerosis and other autoimmune diseases (Hunt
et al., 2008; Esposito et al., 2010). The link between suscepti-
bility to infection and autoimmunity has been long suggested
given the fact that the level and regulation of RGS proteins in
lymphocytes also significantly impact lymphocyte migration and
function. In our pediatric cohort the number of patients with
celiac disease was small (n = 23) and the association was not
detected. Interestingly, one of the major risk variant for celiac
disease, rs13151961 (KIAA1109), as well as known HLA variants,
produced a tread toward association for celiac disease but did not
pass the FDR threshold (data not shown).
Finally we also detected a novel association between mental
retardation and the NDFIP1 gene (Figure 2C, Table 3). Of note,
no effect was detected with Autism at this locus. Indeed, the
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only other effect observed in this region was related to Cerebral
Palsy (p = 9.00× 10−4) and, as mentioned above, an indepen-
dent effect exists for Mental Retardation. The PheWAS code
for mental retardation includes ICD-9 codes for mild, moderate
and profound degrees of retardation as well as not-otherwise-
specified (MR-NOS). Indeed, an additive correlation can also
be detected when we score these subgroups according to sever-
ity excluding the MR-NOS subgroup (p = 3.00× 10−4). Larger
sample size is necessary to fully elucidate this interesting effect.
The Nedd4 family-interacting protein 1 (Ndfip1) is an adaptor
protein for the Nedd4 family of E3 ubiquitin ligases important for
axon and dendrite development. In fact, cerebral atrophy is one
of the main findings in Ndfip1 KO mice (Hammond et al., 2014).
Another neurodevelopmental association effect was observed in
the vicinity of the Phospholipase C-Like 1 (PLCL1, PRIP-1) gene
for overall Developmental Delays-Speech and Language Disorder
(Table 3, Figure 2D). This gene which is expressed predominantly
in brain, regulates the turnover of GABA-receptors, contributes
to the maintenance of GABA-mediated synaptic inhibition, and
has been implicated in several pathologies in animal models and
human including epilepsy, bone density and cancer (Liu et al.,
2008; Zhu et al., 2012). Finally, we also detected a link between
Neuroxin-3 and early onset depression in this study (Table 3).
In fact, this gene has a major role in synaptic plasticity and
function in the nervous system as a receptor and cell adhesion
molecule.
In summary, by using the PheWAS approach and re-mapping
the ICD-9 codes on our European ancestry pediatric cohorts
we have been able to verify and confirm a variety of previ-
ously reported associations as well as discover new effects that
potentially have clinical implications. Similar to adult PheWAS
studies, our data also support the importance of this approach
in pediatrics. We replicated known phenotype-genotype associa-
tions in a pediatric population using these EMR-linked eMERGE
databases, and also noted a number of new possible associations
that warrant additional study, especially including the relation-
ship of PLCL1 to speech and language development and IL5-IL13
to EoE. Some of the limitations to the current PheWAS map
include the fact that current map does not take into account
of the correlation between some phenotypes and treat them as
independent. Future pediatric PheWAS directions will include
enhancements of a PheWAS map for more precise modeling of
trait associations as well as improvements for richer querying and
filtering.
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